These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 34780863)

  • 1. SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein.
    Khaddaj-Mallat R; Aldib N; Bernard M; Paquette AS; Ferreira A; Lecordier S; Saghatelyan A; Flamand L; ElAli A
    Neurobiol Dis; 2021 Dec; 161():105561. PubMed ID: 34780863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.
    Suzuki YJ; Nikolaienko SI; Dibrova VA; Dibrova YV; Vasylyk VM; Novikov MY; Shults NV; Gychka SG
    Vascul Pharmacol; 2021 Apr; 137():106823. PubMed ID: 33232769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
    Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
    Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease.
    Avolio E; Carrabba M; Milligan R; Kavanagh Williamson M; Beltrami AP; Gupta K; Elvers KT; Gamez M; Foster RR; Gillespie K; Hamilton F; Arnold D; Berger I; Davidson AD; Hill D; Caputo M; Madeddu P
    Clin Sci (Lond); 2021 Dec; 135(24):2667-2689. PubMed ID: 34807265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    Paidi RK; Jana M; Mishra RK; Dutta D; Pahan K
    J Immunol; 2021 Nov; 207(10):2521-2533. PubMed ID: 34645689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
    Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Contribution of Cell Adhesion Molecule 1 to the Binding of SARS-CoV-2 Spike Protein to Mouse Nasal Mucosa.
    Takeuchi F; Sugano A; Yoneshige A; Hagiyama M; Inoue T; Wada A; Takaoka Y; Ito A
    Cells Tissues Organs; 2024; 213(4):326-337. PubMed ID: 37903481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection.
    Kaneko N; Satta S; Komuro Y; Muthukrishnan SD; Kakarla V; Guo L; An J; Elahi F; Kornblum HI; Liebeskind DS; Hsiai T; Hinman JD
    Stroke; 2021 Jan; 52(1):260-270. PubMed ID: 33161843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages.
    Satta S; Meng Z; Hernandez R; Cavallero S; Zhou T; Hsiai TK; Zhou C
    Theranostics; 2022; 12(6):2639-2657. PubMed ID: 35401811
    [No Abstract]   [Full Text] [Related]  

  • 11. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications.
    Iwasaki M; Saito J; Zhao H; Sakamoto A; Hirota K; Ma D
    Inflammation; 2021 Feb; 44(1):13-34. PubMed ID: 33029758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spike Protein of SARS-CoV-2 Activates Cardiac Fibrogenesis through NLRP3 Inflammasomes and NF-κB Signaling.
    Van Tin H; Rethi L; Higa S; Kao YH; Chen YJ
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement Activation-Independent Attenuation of SARS-CoV-2 Infection by C1q and C4b-Binding Protein.
    Beirag N; Varghese PM; Neto MM; Al Aiyan A; Khan HA; Qablan M; Shamji MH; Sim RB; Temperton N; Kishore U
    Viruses; 2023 May; 15(6):. PubMed ID: 37376569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
    Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
    J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity.
    Lu J; Sun PD
    J Biol Chem; 2020 Dec; 295(52):18579-18588. PubMed ID: 33122196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local Complement Contributes to Pathogenic Activation of Lung Endothelial Cells in SARS-CoV-2 Infection.
    Zhang H; Gerasimovskaya E; McCarthy MK; May NA; Prasad RR; Riddle S; McKeon BA; Kumar S; Li M; Hu CJ; Frid MG; Morrison TE; Stenmark KR
    Am J Respir Cell Mol Biol; 2023 Aug; 69(2):210-219. PubMed ID: 37071849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Spike Protein Intensifies Cerebrovascular Complications in Diabetic hACE2 Mice through RAAS and TLR Signaling Activation.
    Burnett FN; Coucha M; Bolduc DR; Hermanns VC; Heath SP; Abdelghani M; Macias-Moriarity LZ; Abdelsaid M
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.